US · Healthcare

Nuo Therapeutics Inc (AURX)

Biotechnology

Nuo Therapeutics Inc (AURX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for AURX

P/E ratio

18.00

Nuo Therapeutics Inc (AURX) — FAQ

What is AURX's P/E ratio?

The price-to-earnings (P/E) ratio for Nuo Therapeutics Inc (AURX) is 18.00 (data as of 2026-03-23).

Does Nuo Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nuo Therapeutics Inc (AURX). Check the MyAverix Finance app for the latest dividend data.

What sector is Nuo Therapeutics Inc in?

Nuo Therapeutics Inc (AURX) is classified in the Healthcare sector (Biotechnology industry).

What exchange is AURX listed on?

AURX is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)